This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,364.50 firm fixed-price contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a prescription medication. The contract has a period of performance through November 19, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides both branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare sites.
Generated 1/27/25, 1:11 PM